OBJECTIVE
To determine the prevalence and spectrum of ocular fundus abnormalities in patients with β-thalassemia and to investigate risk factors for their development.
METHODS
Cross-sectional, observational study.
METHODS
A total of 255 patients with β-thalassemia major (TM) and β-thalassemia